发明名称 |
USE OF IGF-1 IN THE MODULATION OF TREG CELL ACTIVITY AND THE TREATMENT AND PREVENTION OF AUTOIMMUNE DISORDERS OR DISEASES |
摘要 |
The present invention relates to the use of the Insulin-like growth factor-I (IGF-1) in immune modulation and/or in the treatment or prevention of pathogenic or aberrant immune responses or disorders and/or for use in the treatment or prevention of T-cell mediated disorders or diseases and/or for use in the treatment or prevention of diseases where the immune system contributes to the disease state. |
申请公布号 |
US2014286906(A1) |
申请公布日期 |
2014.09.25 |
申请号 |
US201214350305 |
申请日期 |
2012.10.05 |
申请人 |
Bilbao Cortes Daniel;Rosenthal Nadia;Luciani Luisa |
发明人 |
Bilbao Cortes Daniel;Rosenthal Nadia;Luciani Luisa |
分类号 |
A61K38/30;C12N5/0783;A61K35/14 |
主分类号 |
A61K38/30 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treatment or prevention of pathogenic or aberrant immune responses or disorders and/or for treatment or prevention of T-cell mediated disorders or diseases and/or for treatment or prevention of diseases where the immune system contributes to the disease state and/or for immune modulation, wherein IGF-1 or a vector expressing IGF 1 is administered to a subject in an amount sufficient to modulate the immune response or to treat or prevent said disorders or diseases. |
地址 |
Rome IT |